5-Bromo-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, 95.0%, 5g

tert-Butyl 2-oxo-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 5g

(E)-3-(FURAN-2-YL)ACRYLALDEHYDE, 95%, 1g

tert-butyl (3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate, 95.0%, 100mg

4-(2-Hydroxypropan-2-yl)picolinic acid, 98%, 250mg

(1S,3S)-(3-Hydroxymethyl-cyclohexyl)-carbamic acid tert-butyl ester, 98%, 100mg

2-(Bromomethyl)-2,3-dihydro-1H-indene, 95.0%, 1g

(R)-(+)-alpha-Methoxy-alpha-(trifluoromethyl)phenylacetic Acid [Optical Resolving]>98.0%(GC)(T)1g

3-Methoxy-5-(trifluoromethyl)phenylboronic acid, 95.0%, 1g

tert-Butyl (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, 97%, 1g

Ethyl 4-allylpiperidine-4-carboxylate hydrochloride, 97%, 250mg

Sapitinib, 99.93%, 5mg

4-(4-BROMO-PHENYL)-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 100mg